Usar pruebas moleculares en Neumonía Adquirida en la Comunidad aumenta la probabilidad de cambiar el manejo antibiótico del paciente. Estamos impactando el tratamiento de nuestros pacientes con @BiofireDX FilmArray Neumonía y salvando vidas. https://t.co/2
RT @Cortes_Penfield: Heard rumors re: new CAP guidelines panel wanting to rec less diagnostic testing. But, the more you look the more you…
RT @Cortes_Penfield: Heard rumors re: new CAP guidelines panel wanting to rec less diagnostic testing. But, the more you look the more you…
Heard rumors re: new CAP guidelines panel wanting to rec less diagnostic testing. But, the more you look the more you find. Among 283 inpts with CAP, more micro tests in the initial 48hrs & esp PCR for atypicals = more targeted vs empiric abx therapy.